Intel GPU Business in a $3.5 Billion Hole, Jon Peddie Recommends Sell or Kill
Intel started reporting revenues from the AXG business since Q1-2021, around which time it started selling its first discrete GPUs as the Intel DG1 Xe MAX, based on the same Xe-LP architecture powering its iGPUs. The company’s Xe-HPG architecture, designed for high-performance gaming, was marketed as its first definitive answer to NVIDIA GeForce and AMD Radeon. Since Q1-2021, Intel has lost $2.1 billion to AXG, with not much to show for. The JPR article suggests that Intel missed the bus both with its time-to-market and scale.
A sizable launch of Arc “Alchemist” in 2021 or early-2022, in the thick of the GPU supply crisis, would have enabled Intel to cash in on sales to whoever is in the market for a graphics card. With the supply crisis over in the wake of the crypto-currency mining demand for dGPUs, Intel finds Arc “Alchemist” competing with GeForce and Radeon products purely on gaming performance, where its fastest “Alchemist” product matches their mid-range products. Both NVIDIA and AMD are ready to ship their next-generation, which is bound to widen the performance gap with Intel even further. Besides graphics, NVIDIA and AMD are ready with even their next-generation scalar compute products, with NVIDIA’s Hopper, and AMD’s CDNA3, increasing the performance gap with “Ponte Vecchio.”
With the recent axing of the Optane Memory business, which rode on the promise of the pioneering 3D XPoint memory technology that Intel invented, it’s open-season on non-performing Intel businesses, especially with CEO Pat Gelsinger seeing favorable outcomes in Washington DC for legislation that makes business favorable for Intel and increases government subsidies for the company. JPR recommends that in light of the losses faced by AXG, Intel should consider selling the entire division off and exiting this market.
The JPR editorial can be read from the source link below.